Clinical Trial Update: A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating TAK-330 to reverse the effects of Factor Xa inhibitors in adults requiring urgent surgery is currently recruiting. The spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulation Disorders

Drugs mentioned

• TAK-330

Snippet

Sponsor: Takeda | Conditions: Coagulation Disorder | Phase 3 | Status: RECRUITING